BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manaithiya A, Alam O, Sharma V, Javed Naim M, Mittal S, Khan IA. GPR119 agonists: Novel therapeutic agents for type 2 diabetes mellitus. Bioorg Chem 2021;113:104998. [PMID: 34048996 DOI: 10.1016/j.bioorg.2021.104998] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Firdaus JU, Siddiqui N, Alam O, Manaithiya A, Chandra K. Identification of novel pyrazole containing ɑ-glucosidase inhibitors: insight into pharmacophore, 3D-QSAR, virtual screening, and molecular dynamics study. Journal of Biomolecular Structure and Dynamics 2022. [DOI: 10.1080/07391102.2022.2141893] [Reference Citation Analysis]
2 El Ashry ESH, Farahat MM, Awad LF, Balbaa M, Yusef H, Badawy ME, Abd Al Moaty MN. New 4-(arylidene)amino-1,2,4-traizole-5-thiol derivatives and their acyclo thioglycosides as α-glucosidase and α-amylase inhibitors: Design, synthesis, and molecular modelling studies. Journal of Molecular Structure 2022;1259:132733. [DOI: 10.1016/j.molstruc.2022.132733] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Singh G, Kajal K, Pradhan T, Bhurta D, Monga V. The medicinal perspective of 2,4-thiazolidinediones based ligands as antimicrobial, antitumor and antidiabetic agents: A review. Arch Pharm (Weinheim) 2022;:e2100517. [PMID: 35715383 DOI: 10.1002/ardp.202100517] [Reference Citation Analysis]
4 Strassheim D, Sullivan T, Irwin DC, Gerasimovskaya E, Lahm T, Klemm DJ, Dempsey EC, Stenmark KR, Karoor V. Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases. Cells 2021;10:3347. [PMID: 34943862 DOI: 10.3390/cells10123347] [Reference Citation Analysis]